Table III.

Single cell analysis of B cells from the MZ of a 56R/B6 mouse

A
Single cells (179)
56R tg+ (124)
Vκ(S) (124)
Vκ38C (100)
Vκ21D
Vλ (26)
    Plate I 67 80 30 11 15 
    Plate II 57 44 70 n.d. 11 
56R tg+ (124)  Vκ (S) (87) Vκ38C (64) Vκ21D Vλ (17) 
    Plate I  58 29 10 
    Plate II  29 35 n.d. 
A
Single cells (179)
56R tg+ (124)
Vκ(S) (124)
Vκ38C (100)
Vκ21D
Vλ (26)
    Plate I 67 80 30 11 15 
    Plate II 57 44 70 n.d. 11 
56R tg+ (124)  Vκ (S) (87) Vκ38C (64) Vκ21D Vλ (17) 
    Plate I  58 29 10 
    Plate II  29 35 n.d. 
B
Cell no.
56R
Vκ(S)/Cκ
Vκ38C/Cκ
Vκ21D/Cκ
Vλ1/Cλ
Plate I      
    10    +a 
    18     +a 
    20  + (Vκ21-4 (98%)/J2 (100%) IF)   +b (IF) 
    22   +a 
    40    
    43   
    53 + + (Vκkk4 (91%)/J5 (95%) IF) + (Vκ38C/J5 IF)  + (Vλ1/Jλ1/Cλ1 IF) 
    59   +a 
    62 + (Vκ38C/J4 IF)  + (Vλ1/Jλ3/Cλ2 OF) 
    63 + (Vκ21-4 (98%)/J2 (100%) IF) + (Vκ38C/J5 IF)  + (Vλ1/Jλ1/Cλ1 OF) 
    74    + (Vλ2/Jλ2/Cλ2 OF) 
    75  + (Vκ21-4 (98%)/J1 (100%) IF)  + (n.d.) 
    76   +a 
    95   + (Vλ1/Jλ1/Cλ1 OF) 
Plate II      
    13  + (Vκ21-4 (98%)/J2 (100%) IF)  n.d. + (Vλ1/Jλ1/Cλ1 IF) 
    14 + (Vκ19-23 (98%)/J5 (100%) IF)  n.d. + (Vλ1/Jλ1/Cλ1 OF) 
    29 + (Vκ21-4%) (98)/J2 (97%) IF)  n.d. + (Vλ1/Jλ3/Cλ? OF) 
    33 + (Vκ19-15 (92%)/J5 (100%) OF) + (Vκ38C/J4 IF) n.d. + (Vλ1/Jλ3/Cλ2 OF) 
    34  + (Vκ38C/J4 IF) n.d. 
    49  + (Vκ38C/J5 IF) n.d. + (Vλ1/Jλ1/Cλ1 OF) 
    52 + (Vκ19-23 (98%)/J2 (100%) IF)  n.d. + (Vλ1/Jλ1/Cλ1 OF) 
    59 + (Vκ21-4 (98%)/J2 (96%) IF) + (Vκ38C/J4 IF) n.d. +a (Vλ1) 
    60  + (Vκkk4 (99%)/J5 (100%) IF) + (Vκ38C/J4 IF) n.d. + (Vλ1/Jλ1/Cλ1 IF) 
    71 + (Vκ19-23 (97%)/J2 (100%) IF) + (Vκ38C/J4 IF) n.d. 
B
Cell no.
56R
Vκ(S)/Cκ
Vκ38C/Cκ
Vκ21D/Cκ
Vλ1/Cλ
Plate I      
    10    +a 
    18     +a 
    20  + (Vκ21-4 (98%)/J2 (100%) IF)   +b (IF) 
    22   +a 
    40    
    43   
    53 + + (Vκkk4 (91%)/J5 (95%) IF) + (Vκ38C/J5 IF)  + (Vλ1/Jλ1/Cλ1 IF) 
    59   +a 
    62 + (Vκ38C/J4 IF)  + (Vλ1/Jλ3/Cλ2 OF) 
    63 + (Vκ21-4 (98%)/J2 (100%) IF) + (Vκ38C/J5 IF)  + (Vλ1/Jλ1/Cλ1 OF) 
    74    + (Vλ2/Jλ2/Cλ2 OF) 
    75  + (Vκ21-4 (98%)/J1 (100%) IF)  + (n.d.) 
    76   +a 
    95   + (Vλ1/Jλ1/Cλ1 OF) 
Plate II      
    13  + (Vκ21-4 (98%)/J2 (100%) IF)  n.d. + (Vλ1/Jλ1/Cλ1 IF) 
    14 + (Vκ19-23 (98%)/J5 (100%) IF)  n.d. + (Vλ1/Jλ1/Cλ1 OF) 
    29 + (Vκ21-4%) (98)/J2 (97%) IF)  n.d. + (Vλ1/Jλ3/Cλ? OF) 
    33 + (Vκ19-15 (92%)/J5 (100%) OF) + (Vκ38C/J4 IF) n.d. + (Vλ1/Jλ3/Cλ2 OF) 
    34  + (Vκ38C/J4 IF) n.d. 
    49  + (Vκ38C/J5 IF) n.d. + (Vλ1/Jλ1/Cλ1 OF) 
    52 + (Vκ19-23 (98%)/J2 (100%) IF)  n.d. + (Vλ1/Jλ1/Cλ1 OF) 
    59 + (Vκ21-4 (98%)/J2 (96%) IF) + (Vκ38C/J4 IF) n.d. +a (Vλ1) 
    60  + (Vκkk4 (99%)/J5 (100%) IF) + (Vκ38C/J4 IF) n.d. + (Vλ1/Jλ1/Cλ1 IF) 
    71 + (Vκ19-23 (97%)/J2 (100%) IF) + (Vκ38C/J4 IF) n.d. 

Single cells from the MZ (B220+CD21high and CD23low) in a 56R/B6 mouse were analyzed by PCR for Igκ, Igλ, and 56R H chain. All PCR product-positive cells were included in the table (A). B cells contained Igλ+ cells. B cells with in-frame λ L chain show message for one or two in-frame κ L chain(s) (in bold) (B). For further details see Table S3. Numbers in parentheses indicate sequence similarity to the germline gene in percentages.

n.d., not done.

IF, in frame.

OF, out of frame.

%, sequence similarity in percent, determined for κ L chains amplified with the degenerate primer V κ (S).

a

Deleterious events in V and J.

b

Deleterious events in V.

Close Modal

or Create an Account

Close Modal
Close Modal